How long does Trametinib last?

Trametinib (Trametinib) is used in combination with the BRAF inhibitor dabrafenib to treat the disease, Trametinib2 mg oral tablet, once a day, Patients should take trametinib alone or in combination with dabrafenib for at least 1 hour, and continue treatment every day. For patients with unresectable or metastatic melanoma or solid tumors, metastatic non-small cell lung cancer (NSCLC), or locally advanced or metastatic anaplastic thyroid cancer (ATC), the recommended duration of treatment is until disease progression or unacceptable toxicity. In the adjuvant melanoma setting, the recommended duration of treatment with trametinib is 1 year until disease recurrence or unacceptable toxicity, and for pediatric patients with low-grade glioma (LGG), the recommended duration of treatment with trametinib is until disease progression or until unacceptable toxicity.